| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5209305
Max Phase: Preclinical
Molecular Formula: C21H18ClFN4O3
Molecular Weight: 428.85
Associated Items:
Representations
Canonical SMILES: O=C1NC(=O)C(N2CCc3c(ncnc3Oc3ccc(F)cc3C3CCC3)C2)=C1Cl
Standard InChI: InChI=1S/C21H18ClFN4O3/c22-17-18(20(29)26-19(17)28)27-7-6-13-15(9-27)24-10-25-21(13)30-16-5-4-12(23)8-14(16)11-2-1-3-11/h4-5,8,10-11H,1-3,6-7,9H2,(H,26,28,29)
Standard InChI Key: IZLJZVDUGKTADC-UHFFFAOYSA-N
Associated Targets(Human)
Short transient receptor potential channel 5 300 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 428.85 | Molecular Weight (Monoisotopic): 428.1051 | AlogP: 3.14 | #Rotatable Bonds: 4 |
| Polar Surface Area: 84.42 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.35 | CX Basic pKa: 2.06 | CX LogP: 2.80 | CX LogD: 2.75 |
| Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.75 | Np Likeness Score: -0.81 |
References
| 1. Zhang Z, Chen L, Tian H, Liu M, Jiang S, Shen J, Wang K, Cao Z.. (2022) Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors., 61 [PMID:35143983] [10.1016/j.bmcl.2022.128612] |
Source
Source(1):